Industry Research Reports

Home > Reports > Chemical & Material > Global Lenalidomide API Market Research Report 2025

Global Lenalidomide API Market Research Report 2025

Industry: Chemical & Material

Published Date: 2025-02-15

Pages: 95 Pages

Report ld: 3954073

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Lenalidomide API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.

North American market for Lenalidomide API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Lenalidomide API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Lenalidomide API include Dr. Reddy’s Laboratories Ltd., Johnson Matthey PLC, Changzhou Pharmaceutical Factory, Shilpa Medicare Limited, Biocon Limited, Sun Pharmaceutical Industries Ltd., Shenzhen Haorui, Mac-Chem Products (India) Pvt.Ltd, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

MARKET SEGMENTATION

By Company

Dr. Reddy’s Laboratories Ltd.
Johnson Matthey PLC
Changzhou Pharmaceutical Factory
Shilpa Medicare Limited
Biocon Limited
Sun Pharmaceutical Industries Ltd.
Shenzhen Haorui
Mac-Chem Products (India) Pvt.Ltd

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Purity≥98%
Purity<98%

Segment by Application

Lenalidomide capsules
Others

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Lenalidomide API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lenalidomide API.

The Lenalidomide API market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lenalidomide API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Lenalidomide API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Lenalidomide API Market Overview

1.1 Product Definition

1.2 Lenalidomide API by Type

1.2.1 Global Lenalidomide API Market Value Growth Rate Analysis by Type: 2024 VS 2031

1.2.2 Purity≥98%

1.2.3 Purity

TABLE OF FIGURES

List of Tables

Table 1. Global Lenalidomide API Market Value by Type, (US$ Million) & (2024 VS 2031)

Table 2. Global Lenalidomide API Market Value by Application, (US$ Million) & (2024 VS 2031)

Table 3. Global Lenalidomide API Production Capacity (Ton) by Manufacturers in 2024

Table 4. Global Lenalidomide API Production by Manufacturers (2020-2025) & (Ton)

Table 5. Global Lenalidomide API Production Market Share by Manufacturers (2020-2025)

Table 6. Global Lenalidomide API Production Value by Manufacturers (2020-2025) & (US$ Million)

Table 7. Global Lenalidomide API Production Value Share by Manufacturers (2020-2025)

Table 8. Global Key Players of Lenalidomide API, Industry Ranking, 2023 VS 2024

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Lenalidomide API as of 2024)

Table 10. Global Market Lenalidomide API Average Price by Manufacturers (US$/Ton) & (2020-2025)

Table 11. Global Key Manufacturers of Lenalidomide API, Manufacturing Base Distribution and Headquarters

Table 12. Global Key Manufacturers of Lenalidomide API, Product Offered and Application

Table 13. Global Key Manufacturers of Lenalidomide API, Date of Enter into This Industry

Table 14. Global Lenalidomide API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Lenalidomide API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Lenalidomide API Production Value (US$ Million) by Region (2020-2025)

Table 18. Global Lenalidomide API Production Value Market Share by Region (2020-2025)

Table 19. Global Lenalidomide API Production Value (US$ Million) Forecast by Region (2026-2031)

Table 20. Global Lenalidomide API Production Value Market Share Forecast by Region (2026-2031)

Table 21. Global Lenalidomide API Production Comparison by Region: 2020 VS 2024 VS 2031 (Ton)

Table 22. Global Lenalidomide API Production (Ton) by Region (2020-2025)

Table 23. Global Lenalidomide API Production Market Share by Region (2020-2025)

Table 24. Global Lenalidomide API Production (Ton) Forecast by Region (2026-2031)

Table 25. Global Lenalidomide API Production Market Share Forecast by Region (2026-2031)

Table 26. Global Lenalidomide API Market Average Price (US$/Ton) by Region (2020-2025)

Table 27. Global Lenalidomide API Market Average Price (US$/Ton) by Region (2026-2031)

Table 28. Global Lenalidomide API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Ton)

Table 29. Global Lenalidomide API Consumption by Region (2020-2025) & (Ton)

Table 30. Global Lenalidomide API Consumption Market Share by Region (2020-2025)

Table 31. Global Lenalidomide API Forecasted Consumption by Region (2026-2031) & (Ton)

Table 32. Global Lenalidomide API Forecasted Consumption Market Share by Region (2026-2031)

Table 33. North America Lenalidomide API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Ton)

Table 34. North America Lenalidomide API Consumption by Country (2020-2025) & (Ton)

Table 35. North America Lenalidomide API Consumption by Country (2026-2031) & (Ton)

Table 36. Europe Lenalidomide API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Ton)

Table 37. Europe Lenalidomide API Consumption by Country (2020-2025) & (Ton)

Table 38. Europe Lenalidomide API Consumption by Country (2026-2031) & (Ton)

Table 39. Asia Pacific Lenalidomide API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Ton)

Table 40. Asia Pacific Lenalidomide API Consumption by Region (2020-2025) & (Ton)

Table 41. Asia Pacific Lenalidomide API Consumption by Region (2026-2031) & (Ton)

Table 42. Latin America, Middle East & Africa Lenalidomide API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Ton)

Table 43. Latin America, Middle East & Africa Lenalidomide API Consumption by Country (2020-2025) & (Ton)

Table 44. Latin America, Middle East & Africa Lenalidomide API Consumption by Country (2026-2031) & (Ton)

Table 45. Global Lenalidomide API Production (Ton) by Type (2020-2025)

Table 46. Global Lenalidomide API Production (Ton) by Type (2026-2031)

Table 47. Global Lenalidomide API Production Market Share by Type (2020-2025)

Table 48. Global Lenalidomide API Production Market Share by Type (2026-2031)

Table 49. Global Lenalidomide API Production Value (US$ Million) by Type (2020-2025)

Table 50. Global Lenalidomide API Production Value (US$ Million) by Type (2026-2031)

Table 51. Global Lenalidomide API Production Value Market Share by Type (2020-2025)

Table 52. Global Lenalidomide API Production Value Market Share by Type (2026-2031)

Table 53. Global Lenalidomide API Price (US$/Ton) by Type (2020-2025)

Table 54. Global Lenalidomide API Price (US$/Ton) by Type (2026-2031)

Table 55. Global Lenalidomide API Production (Ton) by Application (2020-2025)

Table 56. Global Lenalidomide API Production (Ton) by Application (2026-2031)

Table 57. Global Lenalidomide API Production Market Share by Application (2020-2025)

Table 58. Global Lenalidomide API Production Market Share by Application (2026-2031)

Table 59. Global Lenalidomide API Production Value (US$ Million) by Application (2020-2025)

Table 60. Global Lenalidomide API Production Value (US$ Million) by Application (2026-2031)

Table 61. Global Lenalidomide API Production Value Market Share by Application (2020-2025)

Table 62. Global Lenalidomide API Production Value Market Share by Application (2026-2031)

Table 63. Global Lenalidomide API Price (US$/Ton) by Application (2020-2025)

Table 64. Global Lenalidomide API Price (US$/Ton) by Application (2026-2031)

Table 65. Dr. Reddy’s Laboratories Ltd. Lenalidomide API Company Information

Table 66. Dr. Reddy’s Laboratories Ltd. Lenalidomide API Specification and Application

Table 67. Dr. Reddy’s Laboratories Ltd. Lenalidomide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 68. Dr. Reddy’s Laboratories Ltd. Main Business and Markets Served

Table 69. Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates

Table 70. Johnson Matthey PLC Lenalidomide API Company Information

Table 71. Johnson Matthey PLC Lenalidomide API Specification and Application

Table 72. Johnson Matthey PLC Lenalidomide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 73. Johnson Matthey PLC Main Business and Markets Served

Table 74. Johnson Matthey PLC Recent Developments/Updates

Table 75. Changzhou Pharmaceutical Factory Lenalidomide API Company Information

Table 76. Changzhou Pharmaceutical Factory Lenalidomide API Specification and Application

Table 77. Changzhou Pharmaceutical Factory Lenalidomide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 78. Changzhou Pharmaceutical Factory Main Business and Markets Served

Table 79. Changzhou Pharmaceutical Factory Recent Developments/Updates

Table 80. Shilpa Medicare Limited Lenalidomide API Company Information

Table 81. Shilpa Medicare Limited Lenalidomide API Specification and Application

Table 82. Shilpa Medicare Limited Lenalidomide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 83. Shilpa Medicare Limited Main Business and Markets Served

Table 84. Shilpa Medicare Limited Recent Developments/Updates

Table 85. Biocon Limited Lenalidomide API Company Information

Table 86. Biocon Limited Lenalidomide API Specification and Application

Table 87. Biocon Limited Lenalidomide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 88. Biocon Limited Main Business and Markets Served

Table 89. Biocon Limited Recent Developments/Updates

Table 90. Sun Pharmaceutical Industries Ltd. Lenalidomide API Company Information

Table 91. Sun Pharmaceutical Industries Ltd. Lenalidomide API Specification and Application

Table 92. Sun Pharmaceutical Industries Ltd. Lenalidomide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 93. Sun Pharmaceutical Industries Ltd. Main Business and Markets Served

Table 94. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates

Table 95. Shenzhen Haorui Lenalidomide API Company Information

Table 96. Shenzhen Haorui Lenalidomide API Specification and Application

Table 97. Shenzhen Haorui Lenalidomide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 98. Shenzhen Haorui Main Business and Markets Served

Table 99. Shenzhen Haorui Recent Developments/Updates

Table 100. Mac-Chem Products (India) Pvt.Ltd Lenalidomide API Company Information

Table 101. Mac-Chem Products (India) Pvt.Ltd Lenalidomide API Specification and Application

Table 102. Mac-Chem Products (India) Pvt.Ltd Lenalidomide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 103. Mac-Chem Products (India) Pvt.Ltd Main Business and Markets Served

Table 104. Mac-Chem Products (India) Pvt.Ltd Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Lenalidomide API Distributors List

Table 108. Lenalidomide API Customers List

Table 109. Lenalidomide API Market Trends

Table 110. Lenalidomide API Market Drivers

Table 111. Lenalidomide API Market Challenges

Table 112. Lenalidomide API Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Product Picture of Lenalidomide API

Figure 2. Global Lenalidomide API Market Value by Type, (US$ Million) & (2020-2031)

Figure 3. Global Lenalidomide API Market Share by Type: 2024 VS 2031

Figure 4. Purity≥98% Product Picture

Figure 5. Purity

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Lenalidomide API market? zhanKai

The top companies in the global Lenalidomide API market are Dr. Reddy’s Laboratories Ltd.、Johnson Matthey PLC、Changzhou Pharmaceutical Factory.

Related Reports

Lenalidomide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Lenalidomide API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 126
USD 3950.00
(Single User License)
Global Lenalidomide API Market Research Report 2026
The global Lenalidomide API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 134
USD 2900.00
(Single User License)
Global Lenalidomide API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lenalidomide API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 139
USD 4900.00
(Single User License)
Lenalidomide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Lenalidomide API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 99
USD 3950.00
(Single User License)
Global Lenalidomide API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lenalidomide API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 77
USD 4250.00
(Single User License)
Global Lenalidomide API Market Insights, Forecast to 2030
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
Published Date: 2024-04-15
Pages: 95
USD 4900.00
(Single User License)
Lenalidomide API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
Published Date: 2024-02-23
Pages: 97
USD 3950.00
(Single User License)
Global Lenalidomide API Market Research Report 2024
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
Published Date: 2024-01-10
Pages: 85
USD 2900.00
(Single User License)

Lenalidomide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Lenalidomide API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 126
USD 3950.00 (Single User License)
Global Lenalidomide API Market Research Report 2026
The global Lenalidomide API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 134
USD 2900.00 (Single User License)
Global Lenalidomide API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lenalidomide API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 139
USD 4900.00 (Single User License)
Lenalidomide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Lenalidomide API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 99
USD 3950.00 (Single User License)
Global Lenalidomide API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lenalidomide API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 77
USD 4250.00 (Single User License)
Global Lenalidomide API Market Insights, Forecast to 2030
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
Published: 2024-04-15
Pages: 95
USD 4900.00 (Single User License)
Lenalidomide API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
Published: 2024-02-23
Pages: 97
USD 3950.00 (Single User License)
Global Lenalidomide API Market Research Report 2024
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
Published: 2024-01-10
Pages: 85
USD 2900.00 (Single User License)